For the conduct of trials in SGH, approval from the local Institutional Review Board (IRB) is required. The SingHealth Centralised Institutional Review Board (CIRB) is SGH's appointed IRB.
With effect from 1 July 2014, CIRB and NHG-Domain Specific Review Board (DSRB) agreed that the research ethics review conducted by NHG will be recognized by SingHealth and vice versa. For new research studies involving SingHealth Institutions and NHG Institutions, only one IRB application is required.
With effect from 15 September 2014, all new CIRB applications have to be submitted via iSHaRe e-CIRB for review and approval. For sponsored studies, the sponsor is responsible for IRB submission; whereas for Investigator-Initiated trials (IIT), the responsibility lies with the Principal Investigator. Charges apply for each submission. CTRC is able to assist and provide guidance with the submission where necessary.
Singapore General Hospital has worked with most major pharmaceutical companies and CROs, including:
Thank you for considering Clinical Trials and Research Centre for your clinical research needs.
Whether you're approaching us for the first time or have worked with us before, we would like to meet you to find out more. During this meeting, we will cover:
To ensure a fruitful discussion, you will be asked to provide:
Should you decide to engage CTRC for our services, a completed service/facilities request form should be filled up. After which, a study specific budget will be prepared for you based on your service requests. Please allow at least 5 working days for us to get back to you.
Thank you for considering Clinical Trials and Research Centre for your clinical research projects.
Should you wish to find out more, please contact us with the following information: